Melatonin May Curtail the Metabolic Syndrome: Studies on Initial and Fully Established Fructose-Induced Metabolic Syndrome in Rats
Open Access
- 25 January 2013
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (2) , 2502-2514
Abstract
To examine the effect of melatonin given to rats simultaneously with fructose on initial and fully developed metabolic syndrome, male Wistar rats had free access to chow and 5% or 10% fructose drinking solution for 8 weeks. As compared to controls, systolic blood pressure augmented significantly under both treatments whereas excessive body weight was seen in rats receiving the 10% fructose only. Rats drinking 5% fructose showed a greater tolerance to a glucose load while rats having access to a 10% fructose drinking solution exhibited the expected impaired glucose tolerance found in the metabolic syndrome. Circulating triglyceride and low density lipoproteins-cholesterol (LDL-c) concentration augmented significantly in rats showing a fully developed metabolic syndrome only, while high blood cholesterol levels were found at both stages examined. Melatonin (25 μg/mL drinking solution) counteracted the changes in body weight and systolic blood pressure found in rats administered with fructose. Melatonin decreased the abnormal hyperglycemia seen after a glucose load in 10% fructose-treated rats but it did not modify the greater tolerance to glucose observed in animals drinking 5% fructose. Melatonin also counteracted the changes in plasma LDL-c, triglyceride and cholesterol levels and decreased plasma uric acid levels. The results underline a possible therapeutical role of melatonin in the metabolic syndrome, both at initial and established phases.Keywords
This publication has 40 references indexed in Scilit:
- Melatonin and the metabolic syndrome: a tool for effective therapy in obesity‐associated abnormalities?Acta Physiologica, 2012
- Fructose-Fed Rhesus Monkeys: A Nonhuman Primate Model of Insulin Resistance, Metabolic Syndrome, and Type 2 DiabetesClinical and Translational Science, 2011
- Melatonin—A pleiotropic, orchestrating regulator moleculeProgress in Neurobiology, 2011
- Fructose and metabolic diseases: New findings, new questionsNutrition, 2010
- Circadian Rhythms and Metabolic SyndromeCirculation Research, 2010
- Systematic review of long‐term lifestyle interventions to prevent weight gain and morbidity in adultsObesity Reviews, 2009
- Adverse metabolic and cardiovascular consequences of circadian misalignmentProceedings of the National Academy of Sciences, 2009
- Agonistes et antagonistes des récepteurs mélatoninergiques : perspectives thérapeutiquesBiologie Aujourd'hui, 2007
- Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal modelInternational Journal of Experimental Pathology, 2006
- Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential HypertensionHypertension, 2004